Trial Outcomes & Findings for Gout in the ED and Improving Research Participation (NCT NCT04075903)

NCT ID: NCT04075903

Last Updated: 2025-12-03

Results Overview

Proportion of participants who attend a primary care or specialist visits for gout treatment

Recruitment status

ACTIVE_NOT_RECRUITING

Study phase

NA

Target enrollment

200 participants

Primary outcome timeframe

3 months

Results posted on

2025-12-03

Participant Flow

Participant milestones

Participant milestones
Measure
Intervention
Storytelling and Navigation A health literacy-appropriate and culturally-adapted intervention delivered on a tablet computer containing "storytelling" to improve patient gout knowledge and approaches to prevent flares, destigmatize gout, and enhance readiness to adopt available long-term treatments for gout including medications, diet, and exercise, along with post-emergency department visit patient navigation to promote outpatient follow-up
Control
Usual Care
Overall Study
STARTED
135
65
Overall Study
COMPLETED
135
65
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Gout in the ED and Improving Research Participation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention
n=135 Participants
Storytelling and Navigation A health literacy-appropriate and culturally-adapted intervention delivered on a tablet computer containing "storytelling" to improve patient gout knowledge and approaches to prevent flares, destigmatize gout, and enhance readiness to adopt available long-term treatments for gout including medications, diet, and exercise, along with post-emergency department visit patient navigation to promote outpatient follow-up.
Control
n=65 Participants
Usual Care
Total
n=200 Participants
Total of all reporting groups
Age, Continuous
57.6 years
STANDARD_DEVIATION 13.6 • n=3 Participants
58.9 years
STANDARD_DEVIATION 12.4 • n=3 Participants
58 years
STANDARD_DEVIATION 13.1 • n=6 Participants
Sex: Female, Male
Female
34 Participants
n=3 Participants
15 Participants
n=3 Participants
49 Participants
n=6 Participants
Sex: Female, Male
Male
101 Participants
n=3 Participants
50 Participants
n=3 Participants
151 Participants
n=6 Participants
Race/Ethnicity, Customized
Black or African American
92 Participants
n=3 Participants
45 Participants
n=3 Participants
137 Participants
n=6 Participants
Race/Ethnicity, Customized
White
35 Participants
n=3 Participants
16 Participants
n=3 Participants
51 Participants
n=6 Participants
Race/Ethnicity, Customized
Asian, Hispanic or Latino, Unknown/Other
8 Participants
n=3 Participants
4 Participants
n=3 Participants
12 Participants
n=6 Participants
Education Level
High School Graduate or Less
65 Participants
n=3 Participants
30 Participants
n=3 Participants
95 Participants
n=6 Participants
Education Level
Vocational Training or Some College
44 Participants
n=3 Participants
23 Participants
n=3 Participants
67 Participants
n=6 Participants
Education Level
4-year Degree or More Completed
23 Participants
n=3 Participants
12 Participants
n=3 Participants
35 Participants
n=6 Participants
Employment Status
Full-Time Work
61 Participants
n=3 Participants
19 Participants
n=3 Participants
80 Participants
n=6 Participants
Employment Status
Part-Time Work or Not Seeking Work
37 Participants
n=3 Participants
22 Participants
n=3 Participants
59 Participants
n=6 Participants
Employment Status
Unemployed
25 Participants
n=3 Participants
16 Participants
n=3 Participants
41 Participants
n=6 Participants
Employment Status
Other or Choose not to Answer
8 Participants
n=3 Participants
8 Participants
n=3 Participants
16 Participants
n=6 Participants
Yearly Income
Less than $30,000
42 Participants
n=3 Participants
20 Participants
n=3 Participants
62 Participants
n=6 Participants
Yearly Income
$30,000 to less than $60,000
13 Participants
n=3 Participants
13 Participants
n=3 Participants
26 Participants
n=6 Participants
Yearly Income
$60,000 to less than $100,000
14 Participants
n=3 Participants
8 Participants
n=3 Participants
22 Participants
n=6 Participants
Yearly Income
Greater than $100,000
11 Participants
n=3 Participants
4 Participants
n=3 Participants
15 Participants
n=6 Participants
Yearly Income
Prefer not to answer
44 Participants
n=3 Participants
18 Participants
n=3 Participants
62 Participants
n=6 Participants
Smoking Status
Currently Smoking Everyday
17 Participants
n=3 Participants
9 Participants
n=3 Participants
26 Participants
n=6 Participants
Smoking Status
Currently Smoking Some Days
18 Participants
n=3 Participants
4 Participants
n=3 Participants
22 Participants
n=6 Participants
Smoking Status
Not Smoking at All
97 Participants
n=3 Participants
50 Participants
n=3 Participants
147 Participants
n=6 Participants
Alcohol Use
2 or more times per week
24 Participants
n=3 Participants
10 Participants
n=3 Participants
34 Participants
n=6 Participants
Alcohol Use
2-4 times per month
53 Participants
n=3 Participants
22 Participants
n=3 Participants
75 Participants
n=6 Participants
Alcohol Use
Never
54 Participants
n=3 Participants
33 Participants
n=3 Participants
87 Participants
n=6 Participants

PRIMARY outcome

Timeframe: 3 months

Proportion of participants who attend a primary care or specialist visits for gout treatment

Outcome measures

Outcome measures
Measure
Intervention
n=135 Participants
Storytelling and Navigation A health literacy-appropriate and culturally-adapted intervention delivered on a tablet computer containing "storytelling" to improve patient gout knowledge and approaches to prevent flares, destigmatize gout, and enhance readiness to adopt available long-term treatments for gout including medications, diet, and exercise, along with post-emergency department visit patient navigation to promote outpatient follow-up
Control
n=65 Participants
Usual Care
Outpatient Primary Care or Specialist Visits for Gout Treatment
Presence of Gout Follow-Up
64 Participants
35 Participants

Adverse Events

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lesley Jackson, MD, MSPH

University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology

Phone: 205-934-1779

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place